Key facts
- This page summarizes Sandra C. Patterson's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Aug 2023, 16:36.
Sandra C. Patterson - 10 Aug 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)
- Reporting relationship
- SVP, Controllership
- Issuer ticker
- GILD
- Reported as of
- 10 Aug 2023
- Net transaction value
- -$104,480
- SEC form
- 4
- Accepted by SEC
- 11 Aug 2023, 16:36:30 UTC
- Prior SEC filing
- 12 Jun 2023
- Next SEC filing
- 11 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amy Kim by Power of Attorney for Sandra C. Patterson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sandra C. Patterson filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 11 Aug 2023.
Change
- Previous filing in this sequence was filed on 12 Jun 2023.
- Current net transaction value: -$104,480.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GILD
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +4,484
- Change %
- +17%
- Price
- Shares after
- 31,060
- Date
- 10 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
GILD
transaction
Common Stock
Tax liability
- Transaction value
- $104,480
- Shares
- -1,306
- Change %
- -4.2%
- Price
- $80.00
- Shares after
- 29,754
- Date
- 10 Aug 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GILD
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -4,484
- Change %
- -20%
- Price
- Shares after
- 17,557
- Date
- 10 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,484
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Footnote F2
The restricted stock units have a three year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested.